Skip to main navigation Skip to search Skip to main content

Alliance: Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I and Stage II Classical Hodgkin Lymphoma (HL)

Project: Research

Project Details

StatusFinished
Effective start/end date04/15/1502/6/19

Funding

  • National Cancer Institute: $2,250.00